Kiniksa Pharmaceuticals International, plc
Status: Publicly traded
Direct answer
Kiniksa Pharmaceuticals International, plc is publicly traded on NASDAQ under the ticker KNSA.
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an...
Can you invest in Kiniksa Pharmaceuticals International, plc?
Yes. Kiniksa Pharmaceuticals International, plc is publicly traded on NASDAQ under the ticker KNSA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kiniksa Pharmaceuticals International, plc
Detailed equity research is provided by MarketSnap.